Search Results - "Trevino, Jose G"

Refine Results
  1. 1

    The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy by Principe, Daniel R, Underwood, Patrick W, Korc, Murray, Trevino, Jose G, Munshi, Hidayatullah G, Rana, Ajay

    Published in Frontiers in oncology (15-07-2021)
    “…Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with a median survival time of 10-12 months. Clinically, these poor outcomes are attributed to…”
    Get full text
    Journal Article
  2. 2

    The Microbiota and Cancer Cachexia by Herremans, Kelly M, Riner, Andrea N, Cameron, Miles E, Trevino, Jose G

    “…Cancer cachexia is a multifactorial syndrome defined by weight loss, muscle wasting, and systemic inflammation. It affects the majority of patients with…”
    Get full text
    Journal Article
  3. 3
  4. 4

    A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR by Han, Song, Tushoski-Alemán, Gerik W., Zhang, Peiyi, Zheng, Guangrong, Zhou, Daohong, Huo, Zhiguang, Licht, Jonathan, George, Thomas J., Allegra, Carmen, Trevino, Jose G., Hughes, Steven J.

    Published in Neoplasia (New York, N.Y.) (01-01-2025)
    “…•Oncogenic KRAS, the key driver for PDAC, currently lacks effective targeting therapy.•Triple inhibition of MEK, BCL-xL and EGFR showed enhanced tumor…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients by Biel, Thomas G, Petrovskaya, Svetlana, Mascia, Francesca, Ju, Tongzhong, Fashoyin-Aje, Lola, Herremans, Kelly M, Riner, Andrea N, Underwood, Patrick W, Gerber, Michael H, Donoghue, Martha, Trevino, Jose G, Rao, V Ashutosh

    Published in PloS one (22-02-2023)
    “…In pancreatic cancer clinical trials, Black patients are under-represented while having higher morbidity and mortality rates as compared to other racial…”
    Get full text
    Journal Article
  7. 7

    Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer by Tushoski-Alemán, Gerik W, Herremans, Kelly M, Underwood, Patrick W, Akki, Ashwin, Riner, Andrea N, Trevino, Jose G, Han, Song, Hughes, Steven J

    Published in PloS one (12-02-2024)
    “…Pancreatic ductal adenocarcinomas (PDAC) have heterogeneous tumor microenvironments relatively devoid of infiltrating immune cells. We aimed to quantitatively…”
    Get full text
    Journal Article
  8. 8

    Nicotine Induces Inhibitor of Differentiation-1 in a Src-dependent Pathway Promoting Metastasis and Chemoresistance in Pancreatic Adenocarcinoma by Trevino, Jose G, Pillai, Smitha, Kunigal, Sateesh, Singh, Sandeep, Fulp, William J, Centeno, Barbara A, Chellappan, Srikumar P

    Published in Neoplasia (New York, N.Y.) (01-12-2012)
    “…Smoking is a significant risk factor for pancreatic cancer, but the molecular mechanisms by which tobacco smoke components promote the growth and progression…”
    Get full text
    Journal Article
  9. 9

    c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer by Delitto, Daniel, Vertes-George, Eva, Hughes, Steven J, Behrns, Kevin E, Trevino, Jose G

    Published in World journal of gastroenterology : WJG (14-07-2014)
    “…Pancreatic ductal adenocarcinoma is the 4th leading cause of cancer deaths in the United States.The majority of patients are candidates only for palliative…”
    Get full text
    Journal Article
  10. 10

    Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer by Murphy, Kate T, Hossain, Mohammed I, Swiderski, Kristy, Chee, Annabel, Naim, Timur, Trieu, Jennifer, Haynes, Vanessa, Read, Suzannah J, Stapleton, David I, Judge, Sarah M, Trevino, Jose G, Judge, Andrew R, Lynch, Gordon S

    Published in Cancer research (Chicago, Ill.) (15-02-2019)
    “…Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal muscle mass associated with significant functional impairment…”
    Get full text
    Journal Article
  11. 11

    The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine by Herremans, Kelly M, Riner, Andrea N, Cameron, Miles E, McKinley, Kelley L, Triplett, Eric W, Hughes, Steven J, Trevino, Jose G

    Published in Microbiome (15-06-2022)
    “…Pancreatic cancer is a deadly disease with limited diagnostic and treatment options. Not all populations are affected equally, as disparities exist in…”
    Get full text
    Journal Article
  12. 12

    Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model by Cai, Weijing, Ratnayake, Ranjala, Gerber, Michael H., Chen, Qi-Yin, Yu, Yichao, Derendorf, Hartmut, Trevino, Jose G., Luesch, Hendrik

    Published in Investigational new drugs (01-04-2019)
    “…Summary Despite the significant progress in the field of cancer therapeutics, the incidence of pancreatic cancer (PC) has continuously increased. One possible…”
    Get full text
    Journal Article
  13. 13

    Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer by Principe, Daniel R, Underwood, Patrick W, Kumar, Sandeep, Timbers, Kaytlin E, Koch, Regina M, Trevino, Jose G, Munshi, Hidayatullah G, Rana, Ajay

    Published in Frontiers in oncology (28-01-2022)
    “…Transforming Growth Factor β (TGFβ) is a key mediator of immune evasion in pancreatic ductal adenocarcinoma (PDAC), and the addition of TGFβ inhibitors in…”
    Get full text
    Journal Article
  14. 14

    Oncologic and Perioperative Outcomes Following Selective Application of Laparoscopic Pancreaticoduodenectomy for Periampullary Malignancies by Delitto, Daniel, Luckhurst, Casey M., Black, Brian S., Beck, John L., George, Thomas J., Sarosi, George A., Thomas, Ryan M., Trevino, Jose G., Behrns, Kevin E., Hughes, Steven J.

    Published in Journal of gastrointestinal surgery (01-07-2016)
    “…Background Data are sparse regarding patient selection criteria or evaluating oncologic outcomes following laparoscopic pancreaticoduodenectomy (LPD). Having…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Disconnected Pancreatic Duct Syndrome: Disease Classification and Management Strategies by Fischer, Trevan D., MD, Gutman, Daniel S., BS, Hughes, Steven J., MD, FACS, Trevino, Jose G., MD, FACS, Behrns, Kevin E., MD, FACS

    “…Background Disconnected pancreatic duct syndrome (DPDS) typically complicates acute necrotizing pancreatitis (ANP) and presents as a pseudocyst months after…”
    Get full text
    Journal Article
  17. 17

    FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness by Neyroud, Daria, Nosacka, Rachel L., Callaway, Chandler S., Trevino, Jose G., Hu, Hui, Judge, Sarah M., Judge, Andrew R.

    Published in Journal of cachexia, sarcopenia and muscle (01-04-2021)
    “…Background Skeletal muscle wasting is a devastating consequence of cancer that affects up to 80% of cancer patients and associates with reduced survival…”
    Get full text
    Journal Article
  18. 18

    A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer by Delitto, Daniel, MD, PhD, Judge, Sarah M., PhD, George, Thomas J., MD, Sarosi, George A., MD, Thomas, Ryan M., MD, Behrns, Kevin E., MD, Hughes, Steven J., MD, Judge, Andrew R., PhD, Trevino, Jose G., MD

    Published in Surgery (01-04-2017)
    “…Background The relationship between myopenia, nutritional status, and long-term oncologic outcomes remains poorly characterized in patients with clinically…”
    Get full text
    Journal Article
  19. 19

    Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle by Nosacka, Rachel L., Delitto, Andrea E., Delitto, Dan, Patel, Rohan, Judge, Sarah M., Trevino, Jose G., Judge, Andrew R.

    Published in Journal of cachexia, sarcopenia and muscle (01-06-2020)
    “…Background Cancer cachexia is a life‐threatening metabolic syndrome that causes significant loss of skeletal muscle mass and significantly increases mortality…”
    Get full text
    Journal Article
  20. 20

    Human Norovirus Triggers Primary B Cell Immune Activation In Vitro by Mirabelli, Carmen, Jones, Melissa K, Young, Vivienne L, Kolawole, Abimbola O, Owusu, Irene, Shan, Mengrou, Abuaita, Basel, Turula, Holly, Trevino, Jose G, Grigorova, Irina, Lundy, Steven K, Lyssiotis, Costas A, Ward, Vernon K, Karst, Stephanie M, Wobus, Christiane E

    Published in mBio (26-04-2022)
    “…Human norovirus (HNoV) is a global health and socioeconomic burden, estimated to infect every individual at least five times during their lifetime. The…”
    Get full text
    Journal Article